Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Common Name
Da Ren Tang
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
4,619
Ticker
600329
Exchange
SHANGHAI STOCK EXCHANGE
Description
Tianjin Pharmaceutical Da Ren Tang Co., Ltd. is a prominent player in the pharmaceuticals industry, primarily focused on the production and distribution of traditional Chinese medicine (TCM) products....

Da Ren Tang's GHG Emissions Data Preview

In 2023, Da Ren Tang completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Da Ren Tang has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Location-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Download Data

Verified Sources Behind Da Ren Tang’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Da Ren Tang’s data sources below and access millions more through our Disclosure Search.

a. Da Ren Tang's Sustainability Report 2023
a. Da Ren Tang's Sustainability Report 2023

Insights into Da Ren Tang's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Da Ren Tang amounted to 37,390.947 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Da Ren Tang's Scope 1 Emissions Over Time

202301.5 k3 k4.5 k6 ktCO2e
  • Total Scope 1
  • Year-over-Year Change

What are Da Ren Tang's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Da Ren Tang were 5,901.71 metric tons of CO₂ equivalent (tCO₂e). a

What are Da Ren Tang's Scope 2 emissions?

In 2023, Da Ren Tang reported Scope 2 greenhouse gas (GHG) emissions of 31,489.237 tCO₂e using the location-based method. a

What methodology does Da Ren Tang use for Scope 2 reporting?

In 2023, Da Ren Tang reported its Scope 2 emissions using the location-based method. a

Da Ren Tang's Scope 2 Emissions Over Time

202308 k16 k24 k32 ktCO2e
  • Total Scope 2 Location-Based

Insights into Da Ren Tang’s GHG Emissions Intensity Compared to Industry Peers

In 2023, Da Ren Tang reported Scope 1 greenhouse gas (GHG) emissions of 5,901.71 tCO₂e and total revenues of USD 1,157 millions. This translates into an emissions intensity of 5.1 tCO₂e per millions USD. a

Da Ren Tang's Scope 1 Emissions Intensity Compared to Peers

102002,00050,000500,000Scope 1 Emissions (tCO2e)5502002,00010,000Revenues (Millions of USD)CCHPDSCDCanSino BiologicsYear: 2023Scope 1: 3,541 tCO2eRevenue: $M 49Scope 1 Intensity: 72.91 tCO2e/$MSimcere Pharmaceutical GroupYear: 2023Scope 1: 4,997 tCO2eRevenue: $M 1,017Scope 1 Intensity: 4.91 tCO2e/$MWalvax BiotechnologyYear: 2024Scope 1: 7,643 tCO2eRevenue: $M 387Scope 1 Intensity: 19.77 tCO2e/$MCCCR Double-CraneYear: 2023Scope 1: 51,608 tCO2eRevenue: $M 1,438Scope 1 Intensity: 35.88 tCO2e/$MHumanwell Healthcare GroupYear: 2023Scope 1: 23,403 tCO2eRevenue: $M 3,451Scope 1 Intensity: 6.78 tCO2e/$MLuye Pharma GroupYear: 2023Scope 1: 10,755 tCO2eRevenue: $M 945Scope 1 Intensity: 11.38 tCO2e/$MLivzon Pharmaceutical GroupYear: 2024Scope 1: 194,441 tCO2eRevenue: $M 1,619Scope 1 Intensity: 120.13 tCO2e/$MCCChangchun High-TechYear: 2023Scope 1: 61,590 tCO2eRevenue: $M 2,050Scope 1 Intensity: 30.05 tCO2e/$MHansoh Pharmaceutical GroupYear: 2024Scope 1: 13,163 tCO2eRevenue: $M 1,830Scope 1 Intensity: 7.19 tCO2e/$MHHHuadong MedicineYear: 2023Scope 1: 14,289 tCO2eRevenue: $M 5,716Scope 1 Intensity: 2.50 tCO2e/$MJoincareYear: 2024Scope 1: 197,854 tCO2eRevenue: $M 2,140Scope 1 Intensity: 92.45 tCO2e/$MPPPorton Pharma SolutionsYear: 2024Scope 1: 18,865 tCO2eRevenue: $M 413Scope 1 Intensity: 45.71 tCO2e/$MBioKangtaiYear: 2023Scope 1: 15,952 tCO2eRevenue: $M 489Scope 1 Intensity: 32.60 tCO2e/$MZhejiang Jiuzhou PharmaceuticalYear: 2023Scope 1: 48,815 tCO2eRevenue: $M 777Scope 1 Intensity: 62.81 tCO2e/$MYunnan Baiyao GroupYear: 2023Scope 1: 28,983 tCO2eRevenue: $M 5,503Scope 1 Intensity: 5.27 tCO2e/$MConsun Pharmaceutical GroupYear: 2023Scope 1: 54,210 tCO2eRevenue: $M 398Scope 1 Intensity: 136.27 tCO2e/$MDDDong-E-E-JiaoYear: 2023Scope 1: 15,659 tCO2eRevenue: $M 663Scope 1 Intensity: 23.60 tCO2e/$MFosun PharmaYear: 2024Scope 1: 184,016 tCO2eRevenue: $M 5,627Scope 1 Intensity: 32.70 tCO2e/$MSSSihuan PharmaceuticalYear: 2023Scope 1: 45,602 tCO2eRevenue: $M 286Scope 1 Intensity: 159.27 tCO2e/$MTasly Pharmaceutical GroupYear: 2024Scope 1: 37,370 tCO2eRevenue: $M 1,164Scope 1 Intensity: 32.09 tCO2e/$MHua MedicineYear: 2023Scope 1: 19 tCO2eRevenue: $M 12Scope 1 Intensity: 1.63 tCO2e/$MHepalinkYear: 2024Scope 1: 18,284 tCO2eRevenue: $M 724Scope 1 Intensity: 25.27 tCO2e/$MMGI TechYear: 2023Scope 1: 18 tCO2eRevenue: $M 409Scope 1 Intensity: 0.04 tCO2e/$MYuwellYear: 2023Scope 1: 2,201 tCO2eRevenue: $M 1,122Scope 1 Intensity: 1.96 tCO2e/$MCCChina Resources SanjiuYear: 2024Scope 1: 55,312 tCO2eRevenue: $M 3,784Scope 1 Intensity: 14.62 tCO2e/$MDDDa Ren TangYear: 2023Scope 1: 5,902 tCO2eRevenue: $M 1,157Scope 1 Intensity: 5.10 tCO2e/$M

How does Da Ren Tang's GHG emissions intensity compare to its peers?

In 2023, Da Ren Tang reported a Scope 1 emissions intensity of 5.1 tCO₂e per millions USD. Compared to the peer group median of 25.27 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Da Ren Tang rank on GHG emissions intensity within its industry?

In 2023, Da Ren Tang ranked 6 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

Da Ren Tang is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Want Full Access to Da Ren Tang's GHG Emissions Dataset?
Sign Up